Skip to content

Fluorescent Cholangiography in Acute Cholecystitis

The Role of Fluorescent Cholangiography to Improve Operative Safety in Different Severity Degree of Acute Cholecystitis During Emergency Laparoscopic Cholecystectomy.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06573021
Enrollment
81
Registered
2024-08-27
Start date
2023-01-01
Completion date
2024-05-31
Last updated
2024-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis

Keywords

acute cholecystitis, emergency laparoscopic cholecystectomy, near-infrared fluorescent cholangiography, AAST classification

Brief summary

Currently, there is limited scientific evidence regarding the effectiveness of fluorescent cholangiography in emergency cholecystectomy for acute cholecystitis. The primary aim of this study was to assess the efficacy of near-infrared fluorescent cholangiography to detect extrahepatic biliary anatomy in different severity degrees of acute cholecystitis.

Detailed description

The study aims to to evaluate the efficacy of near-infrared fluorescent cholangiography for real-time visualization of the extrahepatic biliary tree (cystic duct, common hepatic duct, cystic duct-common hepatic duct junction, common bile duct and any accessory or aberrant ducts) in emergency laparoscopic cholecystectomy before and after hepatocystic triangle dissection and in different degrees of severity of acute cholecystitis according to the American Association of Surgery for Trauma (AAST) classification, specifically distinguishing between non-gangrenous (grade I) and gangrenous or complicated (grades II-V) forms. For intra-operative fluorescent cholangiography, 2.5 mg indocyanine green (ICG) was administered intravenously 45-60 min prior to surgery, according to the recent guidelines from the International Society for Fluorescence Guided Surgery. All the operations were performed by the same team of surgeons. Near-infrared fluorescent cholangiography was performed by using Stryker's fluorescence imaging system (Stryker, Portage, Miami, USA). Near-infrared fluorescent cholangiography was performed at three defined time point during laparoscopic cholecystectomy: (i) following exposure of Calot's triangle, prior to any dissection; (ii) after partial dissection of Calot's triangle; (iii) after complete dissection of Calot's triangle, according to the Critical View of Safety method.

Interventions

DRUGNear-infrared fluorescent cholangiography

For intra-operative fluorescent cholangiography, 2.5 mg indocyanine green (ICG, Pulsion Medical Inc., Irving, Tx) was administered intravenously 45-60 min prior to surgery, according to the recent guidelines from the International Society for Fluorescence Guided Surgery (ISFGS) and the latest consensus conference published in 2021.

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a clinical and radiological (abdominal ultrasound and/or computed tomography) diagnosis of acute cholecystitis based on the revised TG18 who underwent laparoscopic cholecystectomy within 24-72 hours from the onset of symptoms; * patients with ASA score of 1-3;

Exclusion criteria

* patients with a known allergy to indocyanine green; * ASA score 4-5; * patients deemed non-operable via laparoscopic approach due to high cardio-respiratory risk; * previous surgical interventions on the biliary tract; * history of liver cirrhosis or severe liver disease; * ongoing pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of near-infrared fluorescent cholangiography in emergency cholecystectomyFrom start of surgery to the end of Calot's triangle dissectionThe primary aim was to analyze the correct visualization by fluorescence of extrahepatic bile ducts (cystic duct, common hepatic duct, cystic duct-common hepatic duct junction, common bile duct, and any accessory or aberrant ducts) before and after Calot's dissection in different grades of severity of acute cholecystitis according to the AAST classification, particularly distinguishing non-gangrenous forms (grade I) from gangrenous and complicated forms (grades II-V).

Secondary

MeasureTime frameDescription
The bail-out procedures rate in emergency cholecystectomy by fluorescenceperioperativelyBail-out procedures during surgery, such as subtotal cholecystectomy, antegrade cholecystectomy
The rate of bile duct injuries in emergency cholecystectomy by fluorescenceperioperativelyIatrogenic bile duct injuries
Conversion rate in emergency cholecystectomy by fluorescenceperioperativelyConversion rate (from laparoscopy to open approach)
Analysis of post-operative complications in emergency cholecystectomy by fluorescenceup to 30 daysPostoperative complications according to Clavien-Dindo classification
The length of stay in emergency cholecystectomy by fluorescenceperioperativelyLength of hospital stay
The duration of surgery in emergency cholecystectomy by fluorescenceperioperativelyTotal surgery duration (minutes)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026